Comprehensive analysis on market size, growth drivers, trends, opportunities, and competitive developments in the North America Fluoroscopy Equipment Market from 2020 to 2035.
The economic impact of tariffs on "North America Fluoroscopy Equipment Market".
Market Growth Drivers
Rising Incidence of Chronic Diseases: The prevalence of chronic diseases such as cardiovascular disorders, cancer, and orthopedic conditions has increased significantly across North America. This has led to a higher demand for advanced diagnostic procedures, such as those facilitated by fluoroscopy equipment. Companies like GE Healthcare are investing heavily in product innovation to provide enhanced imaging solutions aimed at precise diagnostics and interventional procedures. As healthcare providers seek to improve patient outcomes by adopting cutting-edge technologies, the adoption of fluoroscopy equipment is set to surge, driving market growth.
Technological Advancements and Adoption of Digital Fluoroscopy: The shift from conventional analog systems to digital fluoroscopy equipment is revolutionizing the market. Major players such as Siemens Healthineers have introduced systems with improved image quality, reduced radiation dose, and enhanced workflow efficiency. Such advancements, coupled with integration of AI and 3D imaging, are attracting hospitals and outpatient centers to upgrade their existing installations. This trend is supported by substantial investments in R&D from companies seeking competitive edge through improved clinical capabilities.
Market Trends
Increased Integration of Artificial Intelligence: The use of artificial intelligence (AI) in fluoroscopy equipment has gained momentum, allowing enhanced image reconstruction, dose optimization, and real-time decision support. Companies like Philips are pioneering the incorporation of AI algorithms to aid radiologists in diagnostics, improving workflow efficiency and accuracy. The automation of repetitive tasks and smarter image analytics are expected to transform fluoroscopy practices across North American healthcare settings.
Growing Preference for Portable and Mobile Fluoroscopy Systems: The COVID-19 pandemic highlighted the need for mobility and flexibility in imaging solutions. As a result, there is increasing adoption of portable and mobile fluoroscopy units, particularly in emergency rooms and outpatient surgery centers. Hologic Inc. and other leading companies have developed lightweight and user-friendly systems that deliver high-quality imaging at the point of care. This trend addresses the demand for quicker diagnostic procedures and supports more decentralized healthcare delivery models.
Market Opportunities
Expansion in Ambulatory Surgery Centers: The shift towards outpatient and minimally invasive procedures is increasing the demand for advanced fluoroscopy systems in ambulatory surgery centers throughout North America. Companies like Canon Medical Systems are strategically partnering with healthcare providers to deliver tailored solutions for these fast-growing care settings.
Telehealth and Remote Diagnostics: The expansion of telehealth networks offers opportunities for remote diagnostics, where fluoroscopy images can be shared and interpreted by experts across different locations. This facilitates partnerships between technology providers and healthcare IT companies to offer integrated solutions, resulting in expanded market reach.
North America Fluoroscopy Equipment Market Revenue (USD Million), 2020-2035
The market witnessed steady growth from 2020, valued at USD 1,500 Million, with the revenue increasing each year due to rising adoption of advanced imaging technology and growing healthcare investments. By 2025, the market is projected to reach USD 2,050 Million and continue its upward trajectory. Major surges are forecasted post-2027, as regulatory support and technological advancements proliferate. The market is expected to attain USD 3,650 Million by 2035, driven by ongoing innovations in digital fluoroscopy and expansion into ambulatory settings. The CAGR over the forecast period is estimated at 6.3%.
North America Fluoroscopy Equipment Market Regional Share, 2025
In 2025, the United States dominates the North America fluoroscopy equipment market, accounting for approximately 79% of the total share due to its advanced healthcare infrastructure and significant investments in medical imaging technologies. Canada follows with a 14% share, leveraging substantial government support for healthcare modernization. Mexico represents 5% of the market, with adoption rates rising in private hospitals. The remaining 2% is distributed among smaller regions and territories. The chart underscores the entrenched position of the US as the primary driver for market growth in the continent.
Recent Market Developments
In March 2024, Siemens Healthineers announced the U.S. FDA clearance for its newest generation of hybrid fluoroscopy and angiography systems. The system features advanced visualization tools and integrated 3D imaging, specifically targeting complex orthopedic and cardiovascular procedures. This development reflects the company's commitment to next-gen digital imaging and precision medicine.
In April 2024, GE Healthcare entered a strategic partnership with Mayo Clinic to deploy digital fluoroscopy systems across multiple clinical sites. This collaboration is aimed at both workflow optimization and lowering radiation dosage for patients. The installations will support clinical research initiatives to investigate the efficacy of AI-powered dose reduction algorithms in routine practice.
In June 2024, Philips introduced a fully mobile C-arm fluoroscopy system designed for use in outpatient and ambulatory surgery centers across North America. The device's intuitive interface, combined with wireless data integration, underlines a market shift towards decentralized care and improved accessibility. Philips has reported strong demand, signaling robust growth in this product segment over the next several years.
Press Releases